{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T03:05:57Z","timestamp":1787799957008,"version":"build-2784847793"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,3]]},"abstract":"<jats:p>Cervical cancer screening has significantly reduced the incidence of cervical cancer in the United States. National recommendations have evolved to keep pace with advancement in our understanding of human papilloma virus (HPV) biology as well as improvements in HPV testing. This chapter summarizes present national screening guidelines, reviews information regarding recent development in HPV biology and testing, discusses some of the controversies related to screening and provides clinicians with talking points for their patients.<\/jats:p>","DOI":"10.1097\/grf.0000000000000336","type":"journal-article","created":{"date-parts":[[2017,12,16]],"date-time":"2017-12-16T00:41:43Z","timestamp":1513384903000},"page":"40-51","source":"Crossref","is-referenced-by-count":8,"title":["Cervical Cancer Screening"],"prefix":"10.1097","volume":"61","author":[{"given":"RICHARD","family":"GUIDO","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20240213","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GRF.0b013e318282b982","article-title":"The evolution of the Papanicolaou smear","volume":"56","author":"Tambouret","year":"2013","journal-title":"Clin Obstet Gynecol"},{"key":"R2-20240213","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0301-2115(00)00260-8","article-title":"The Pap test: George N. Papanicolau (1883-1962) a screening test for the prevention of cancer of the uterine cervix","volume":"90","author":"Michalas","year":"2000","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R4-20240213","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/LGT.0b013e31824ca9d5","article-title":"American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the prevention and early detection of cervical cancer","volume":"16","author":"Saslow","year":"2012","journal-title":"J Low Genit Tract Dis"},{"key":"R5-20240213","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ijc.25396","article-title":"Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide; variation by geographical region, histological type and year of publication","volume":"128","author":"Li","year":"2011","journal-title":"Int J Cancer"},{"key":"R6-20240213","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jnci\/dji187","article-title":"The elevated 10-year risk of cervical precancer and cancer in women with HPV type 16 or 18 and the possible utility of type-specific HPV tesing in clinical practice","volume":"97","author":"Khan","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"R7-20240213","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","article-title":"Human papillomavirus and cervical cancer","volume":"370","author":"Schiffman","year":"2007","journal-title":"Lancet"},{"key":"R8-20240213","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(08)70103-7","article-title":"Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study","volume":"9","author":"McCredie","year":"2008","journal-title":"Lancet Oncol"},{"key":"R9-20240213","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/LGT.0b013e31823da811","article-title":"An audit of the cervical cancer screening histories of 246 women with carcinoma","volume":"16","author":"Duggan","year":"2012","journal-title":"J Low Genit Tract Dis"},{"key":"R10-20240213","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ygyno.2017.06.003","article-title":"Why does cervical cancer occur in a state-of-the-art screening program?","volume":"146","author":"Castle","year":"2017","journal-title":"Gynecol Oncol"},{"key":"R11-20240213","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10552-015-0678-1","article-title":"Comparing SurePath, ThinPrep, and conventional cytology as primary test method: SurePath is associated with increased CIN II+ detection rates","volume":"27","author":"Rozemeijer","year":"2016","journal-title":"Cancer Causes Control"},{"key":"R13-20240213","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/jnci\/93.4.293","article-title":"Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial","volume":"93","author":"Solomon","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"R14-20240213","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1186\/1756-0500-7-544","article-title":"Factors associated with genital human papillomavirus infection among adult females in the United States, NHANES 2007\u20132010","volume":"7","author":"Shi","year":"2014","journal-title":"BMC Res Not"},{"key":"R15-20240213","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/sj.bjc.6600974","article-title":"Benefit of cervical screening at different ages: evidence from the UK audit of screening histories","volume":"89","author":"Sasieni","year":"2003","journal-title":"Br J Cancer"},{"key":"R16-20240213","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/AOG.0000000000000632","article-title":"Increased cervical cancer risk associated with screening at longer intervals","volume":"125","author":"Kinney","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R17-20240213","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/LGT.0b013e3182616241","article-title":"Screening for cervical cancer: a modeling study for the US Preventive Services Task Force","volume":"17","author":"Kulasingam","year":"2013","journal-title":"J Low Genit Tract Dis"},{"key":"R18-20240213","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/jnci\/djp089","article-title":"Cervical intraepithelial neoplasia outcomes after treatment: long-term follow-up from the British Columbia Cohort Study","volume":"101","author":"Melnikow","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"R19-20240213","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/ijc.30524","article-title":"Harms of cervical cancer screening in the United States and the Netherlands","volume":"140","author":"Habbema","year":"2017","journal-title":"Int J Cancer"},{"key":"R20-20240213","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","article-title":"Efficacy of human papillomavirus testing for the detection of invasive cervical cancer and cervical intraepithelial neoplasia: a randomized control trial","volume":"11","author":"Ronco","year":"2010","journal-title":"Lancet Oncol"},{"key":"R21-20240213","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/bjc.2016.368","article-title":"Disease detection and resource use in the safety and control arms of the HPV FOCAL cervical cancer screening trial","volume":"115","author":"Coldman","year":"2016","journal-title":"Br J Cancer"},{"key":"R22-20240213","doi-asserted-by":"crossref","first-page":"e7789","DOI":"10.1136\/bmj.e7789","article-title":"Detection rates of precancerous and cancerous cervical lesions within one screening round of primary HPV DNA testing: prospective randomized trial in Finland","volume":"345","author":"Leinonen","year":"2012","journal-title":"BMJ"},{"key":"R23-20240213","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ygyno.2014.11.076","article-title":"Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test","volume":"136","author":"Wright","year":"2015","journal-title":"Gynecol Oncol"},{"key":"R24-20240213","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/LGT.0000000000000103","article-title":"Use of primary high-risk HPV testing for cervical cancer screening: interim clinical guidance","volume":"19","author":"Huh","year":"2015","journal-title":"J Lower Gen Tract Dis"},{"key":"R25-20240213","doi-asserted-by":"crossref","first-page":"874","DOI":"10.15585\/mmwr.mm6633a2","article-title":"National, regional, state and selected local area vaccination coverage among adolescents age 13-17-United States 2016","volume":"66","author":"Walker","year":"2017","journal-title":"Morb Mortal Wkly Rep"},{"key":"R26-20240213","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1159\/000338555","article-title":"Heavy cervical cancer burden in elderly women: how can we improve the situation","volume":"56","author":"Skaznik-Wikiel","year":"2012","journal-title":"Acta Cytol"},{"key":"R28-20240213","first-page":"923","article-title":"Practice Bulletin No. 168. Summary: cervical cancer screening and prevention","volume":"128","author":"Chelmow","year":"2016","journal-title":"Obstet Gynecol"}],"container-title":["Clinical Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003081-201803000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T06:01:09Z","timestamp":1707804069000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003081-201803000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/grf.0000000000000336","relation":{},"ISSN":["0009-9201"],"issn-type":[{"value":"0009-9201","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]}}}